Thrombosis |
From the Divisions of Clinical Chemistry (A.M., T.T., A.S.), Cardiology (N.J., B.L., L.W.), and Molecular Medicine (T.A., A-C.S.), Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Correspondence to Agneta Siegbahn, Department of Medical Sciences, Clinical Chemistry, Uppsala University, S-751 85 Uppsala, Sweden. E-mail agneta.siegbahn{at}akademiska.se
Objective Tissue factor (TF) has, among other factors, a prominent role in acute coronary syndrome (ACS). Our goal was to investigate whether single nucleotide polymorphisms (SNP) in the TF gene (F3) are associated with plasma TF, risk, and outcome in patients with ACS. Moreover, we wanted to investigate the impact of associated TF SNPs on mRNA production in human monocytes.
Methods and Results In 725 patients with ACS [Fragmin and Fast Revascularization during Instability in Coronary Artery Disease II (FRISC-II) study] and 376 controls, 13 SNPs were genotyped and plasma TF measured. Thereafter, the 5466 A>G and the 1812 C>T were genotyped among all of the FRISC-II participants (n=3143) and assessed concerning clinical outcome. Associated SNPs were genotyped in 92 healthy blood donors for comparison of TF activity and TF mRNA expression. None of the SNPs were associated with patient/control status. The 5466 A>G SNP was associated with cardiovascular death (odds ratio, 1.8; P=0.025). The CG haplotype by 1812 C>T and 5466 A>G was associated with a 3-fold increased risk of death (P<0.001). TF mRNA and basal TF activity was significantly lower among 5466 AG carriers, whereas the increase in monocyte TF activity on lipopolysaccharide stimulation was significantly stronger (P=0.04).
Conclusions The 5466 AG genotype is a novel predictor of cardiovascular death in ACS and may act through a high TF response.
Polymorphisms in the tissue factor gene were investigated concerning association with risk and outcome in patients with acute coronary syndrome. The TF 5466 AG genotype was associated with cardiovascular death. In vitro endotoxin induced a relative increase in monocytic TF activity, which was significantly higher in AG compared with AA carriers.
Key Words: acute coronary syndrome tissue factor single nucleotide polymorphism outcome mRNA
This article has been cited by other articles:
![]() |
E. Shantsila and G. Y.H. Lip Monocytes in Acute Coronary Syndromes Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1433 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jiang, C. Y. Liu, Q. F. Yang, P. Wang, and W. Zhang Plasma Level of Growth Arrest-Specific 6 (GAS6) Protein and Genetic Variations in the GAS6 Gene in Patients With Acute Coronary Syndrome Am J Clin Pathol, May 1, 2009; 131(5): 738 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Malarstig, P Eriksson, A Hamsten, B Lindahl, L Wallentin, and A Siegbahn Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome Heart, June 1, 2008; 94(6): 724 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Campo, M. Valgimigli, P. Ferraresi, P. Malagutti, M. Baroni, C. Arcozzi, D. Gemmati, G. Percoco, G. Parrinello, R. Ferrari, et al. Tissue Factor and Coagulation Factor VII Levels During Acute Myocardial Infarction: Association With Genotype and Adverse Events Arterioscler Thromb Vasc Biol, December 1, 2006; 26(12): 2800 - 2806. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Steffel, T. F. Luscher, and F. C. Tanner Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications Circulation, February 7, 2006; 113(5): 722 - 731. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |